Resources for Clinicians
The PSYCKES team has developed an array of resources to support clinicians in providing their clients with the most effective treatment services while minimizing the risk of adverse effects. Available resources include information about the PSYCKES quality concerns, tools for clinical practice, and help with using the PSYCKES application.
- Scientific Summary #15. (62kb) A 2011 randomized controlled trial published in the American Journal of Psychiatry evaluated the benefits and risks of staying on antipsychotic polypharmacy ("stay") vs. switching to monotherapy ("switch"). The majority of the "switch" group was able to successfully transition to monotherapy without significant differences in symptom control compared to the "stay" group. The "switch" group also showed improved body mass index (BMI).
Comments or questions about the information on this page can be directed to the PSYCKES Team.